References

1. Li S, Ma Z. Nonviral gene therapy. Curr Gene Ther 2001; 1: 201-226.

2. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL. Direct gene transfer into mouse muscle in vivo. Science 1990; 247:1465-1468.

3. Acsadi G, Dickson G, Love DR, Jani A, Walsh FS, Gurusinghe A, Wolff JA, Davies KE. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 1991; 352:815-818.

4. Tsurumi Y, Takeshita S, Chen D, Kearney M, Rossow ST, Passeri J, Horowitz JR, Symes JF, Isner JM. Direct intramuscular gene transfer of naked DNA encoding vascular endothe-lial growth factor augments collateral development and tissue perfusion. Circulation 1996; 94:3281-3290.

5. Danko I, Wolff JA. Direct gene transfer into muscle. Vaccine 1994; 12:1499-1502.

6. Smith LC, Nordstrom JL. Advances in plasmid gene delivery and expression in skeletal muscle. Curr Opin Mol Ther 2000; 2:150-154.

7. Lucas ML, Heller L, Coppola D, Heller R. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol Ther 2002; 5:668-675.

8. Matsubara H, Gunji Y, Maeda T, Tasaki K, Koide Y, Asano T, Ochiai T, Sakiyama S, Tagawa M. Electroporation-mediated transfer of cytokine genes into human esophageal tumors produces anti-tumor effects in mice. Anticancer Res 2001; 21: 2501-2503.

9. Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti RC, Fenske NA, Gilbert RA, Mir LM, Reintgen DS. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996; 77:964-971.

10. Gehl J, Skovsgaard T, Mir LM. Enhancement of cytotoxicity by electropermeabilization: An improved method for screening drugs. Anticancer Drugs 1998; 9:319-325.

11. Lesbordes JC, Bordet T, Haase G, Castelnau-Ptakhine L, Rou-hani S, Gilgenkrantz H, Kahn A. In vivo electrotransfer of the cardiotrophin-1 gene into skeletal muscle slows down progression of motor neuron degeneration in pmn mice. Hum Mol Genet 2002; 11:1615-1625.

12. Vilquin JT, Kennel PF, Paturneau-Jouas M, Chapdelaine P, Boissel N, Delaere P, Tremblay JP, Scherman D, Fiszman

MY, Schwartz K. Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies. Gene Ther 2001; 8:1097-1107.

13. Lucas ML, Jaroszeski MJ, Gilbert R, Heller R. In vivo elec-troporation using an exponentially enhanced pulse: A new waveform. DNA Cell Biol 2001; 20:183-188.

14. Yasui A, Oda K, Usunomiya H, Kakudo K, Suzuki T, Yoshida T, Park HM, Fukazawa K, Muramatsu T. Elevated gastrin secretion by in vivo gene electroporation in skeletal muscle. Int J Mol Med 2001; 8:489-494.

15. Terada Y, TanakaH, Okado T, InoshitaS, KuwaharaM, Akiba T, Sasaki S, Marumo F. Efficient and ligand-dependent regulated erythropoietin production by naked DNA injection and in vivo electroporation. Am J Kidney Dis 2001; 38:S50-S53.

16. Fewell JG, MacLaughlin F, Mehta V, Gondo M, Nicol F, Wilson E, Smith LC. Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation. Mol Ther 2001; 3:574-583.

17. Draghia-Akli R, Fiorotto ML, Hill LA, Malone PB, Deaver DR, Schwartz RJ. Myogenic expression of an injectable pro-tease-resistant growth hormone-releasing hormone augments long-term growth in pigs. Nat Biotechnol 1999; 17: 1179-1183.

18. Draghia-Akli R, Malone PB, Hill LA, Ellis KM, Schwartz RJ, Nordstrom JL. Enhanced animal growth via ligand-regulated GHRH myogenic-injectable vectors. FASEB J 2002; 16: 426-428.

19. Gehl J, Sorensen TH, Nielsen K, Raskmark P, Nielsen SL, Skovsgaard T, Mir LM. In vivo electroporation of skeletal muscle: Threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1999; 1428:233-240.

20. Gehl J, Mir LM. Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem Biophys Res Commun 1999; 261:377-380.

21. Hartikka J, Sukhu L, Buchner C, Hazard D, Bozoukova V, Margalith M, Nishioka WK, Wheeler CJ, Manthorp M, Saw-dey M. Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: Plasmid dependence of muscle damage and effect of poloxamer 188. Mol Ther 2001; 4:407-415.

22. Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 1999; 6:508-514.

23. Miklavcic D, Semrov D, Mekid H, Mir LM. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 2000; 1523:73-83.

24. Somiari S, Glasspool-Malone J, DrabickJJ, Gilbert RA, Heller R, Jaroszeski MJ, Malone RW. Theory and in vivo application of electroporative gene delivery. Mol Ther 2000; 2:178-187.

25. Neumann E, Kakorin S, Toensing K. Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem Bioenerg 1999; 48:3-16.

26. Fear EC, Stuchly MA. Biological cells with gap junctions in low-frequency electric fields. IEEE Trans Biomed Eng 1998; 45:856-866.

27. Li S, Zhang X, Xia X. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy. J Natl Cancer Inst 2002; 94:762-768.

28. Gehl J, Geertsen PF. Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res 2000; 10:585-589.

29. Gilbert RA, Jaroszeski MJ, Heller R. Novel electrode designs for electrochemotherapy. Biochim Biophys Acta 1997; 1334: 9-14.

30. Heller R, Jaroszeski M, Atkin A, Moradpour D, Gilbert R, Wands J, Nicolau C. In vivo gene electroinjection and expression in rat liver. FEBS Lett 1996; 389:225-228.

31. Liu F, Huang L. Electric gene transfer to the liver following systemic administration of plasmid DNA. Gene Ther 2002; 9: 1116-1119.

32. Jaroszeski MJ, Gilbert RA, Heller R. In vivo antitumor effects of electrochemotherapy in a hepatoma model. Biochim Biophys Acta 1997; 1334:15-18.

33. Zhang L, Nolan E, Kreitschitz S, Rabussay DP. Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation. Biochim Biophys Acta 2002; 1572:1-9.

34. Maruyama H, Ataka K, Higuchi N, Sakamoto F, Gejyo F, Miyazaki J. Skin-targeted gene transfer using in vivo elec-troporation. Gene Ther 2001; 8:1808-1812.

35. Li S, MacLaughlin FC, Fewell JG, Li Y, Mehta V, French MF, Nordstrom JL, Coleman M, Belagali NS, Schwartz RJ, Smith LC. Increased level and duration of expression in muscle by co-expression of a transactivator using plasmid systems. Gene Ther 1999; 6:2005-2011.

36. McMahon JM, Signori E, Wells KE, Fazio VM, Wells DJ. Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase—Increased expression with reduced muscle damage. Gene Ther 2001; 8:1264-1270.

37. Molon-Noblot S, Laroque P, Prahalada S, Stabinski LG, Hoe CM, Peter CP, Duprat P, Zwieten MJ. Effect of chronic growth hormone administration on skeletal muscle in dogs. Toxicol Pathol 1998; 26:207-212.

38. Beermann DH, Fishell VK, Roneker K, Boyd RD, Armbruster G, Souza L. Dose-response relationships between porcine so-matotropin, muscle composition, muscle fiber characteristics and pork quality. J Anim Sci 1990; 68:2690-2697.

39. Lee RC, Hannig J, Matthews KL, Myerov A, Chen CT. Pharmaceutical therapies for sealing of permeabilized cell membranes in electrical injuries. Ann NY Acad Sci 1999; 888: 266-273.

40. Mumper RJ, Wang J, Klakamp SL, Nitta H, Anwer K, Tagliaf-erri F, Rolland AP. Protective interactive noncondensing (PINC) polymers for enhanced plasmid distribution and expression in rat skeletal muscle. J Control Release 1998; 52: 191-203.

41. Nicol F, Wong M, MacLaughlin FC, Perrard J, Wilson E, Nordstrom JL, Smith LC. Poly-L-glutamate, an anionic polymer, enhances transgene expression for plasmids delivered by intramuscular injection with in vivo electroporation. Gene Ther 2002; 9:1351-1358.

42. Draghia-Akli R, Khan AS, Cummings KK, Parghi D, Carpenter RH, Brown PA. Electrical enhancement of formulated plasmid delivery in animals. Tech Cancer Res Treatment 2002; 1:365-371.

43. Mennuni C, Calvaruso F, Zampaglione I, Rizzuto G, Rinaudo D, Dammassa E, Ciliberto G, Fattori E, La Monica N. Hyal-uronidase increases electrogene transfer efficiency in skeletal muscle. Hum Gene Ther 2002; 13:355-365.

44. Chen ZY, Yant SR, He CY, Meuse L, Shen S, Kay MA. Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver. Mol Ther 2001; 3:403-410.

45. Stan AC, Casares S, Brumeanu TD, Klinman DM, Bona CA. CpG motifs of DNA vaccines induce the expression of chemo-kines and MHC class II molecules on myocytes. Eur J Immunol 2001; 31:301-310.

46. Yew NS, Zhao H, Przybylska M, Wu IH, Tousignant JD, Scheule RK, Cheng SH. CpG-Depleted Plasmid DNA Vectors with enhanced safety and long-term gene expression in vivo. Mol Ther 2002; 5:731-738.

47. Soubrier F, Cameron B, Manse B, Somarriba S, Dubertret C, Jaslin G, Jung G, Caer CL, Dang D, Mouvault JM, Scherman D, Mayaux JF, Crouzet J. pCOR: A new design of plasmid vectors for nonviral gene therapy. Gene Ther 1999; 6: 1482-1488.

48. Darquet AM, Rangara R, Kreiss P, Schwartz B, Naimi S, De-laere P, Crouzet J, Scherman D. Minicircle: An improved DNA molecule for in vitro and in vivo gene transfer. Gene Ther 1999; 6:209-218.

49. Li X, Eastman EM, Schwartz RJ, Draghia-Akli R. Synthetic muscle promoters: Activities exceeding naturally occurring regulatory sequences. Nat Biotechnol 1999; 17:241-245.

50. Chastain M, Simon AJ, Soper KA, Holder DJ, Montgomery DL, Sagar SL, Casimiro DR, Middaugh CR. Antigen levels and antibody titers after DNA vaccination. J Pharm Sci 2001; 90:474-484.

51. Aihara H, Miyazaki J. Gene transfer into muscle by electropor-ation in vivo. Nat Biotechnol 1998; 16:867-870.

52. Li S, Benninger M. Applications of muscle electroporation gene therapy. Curr Gene Ther 2002; 2:101-105.

53. Imai E, Isaka Y. Gene electrotransfer: Potential for gene therapy of renal diseases. Kidney Int 61 2002; 37-41(Suppl 1): 37-41.

54. Prud'homme GJ, Lawson BR, Theofilopoulos AN. Anticytok-ine gene therapy of autoimmune diseases. Expert Opin Biol Ther 2001; 1:359-373.

55. Mir LM, Bureau MF, Rangara R, Schwartz B, Scherman D. Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. C R Acad Sci III 1998; 321:893-899.

56. Muramatsu T, Arakawa S, Fukazawa K, Fujiwara Y, Yoshida T, Sasaki R, Masuda S, Park HM. In vivo gene electroporation in skeletal muscle with special reference to the duration of gene expression. Int J Mol Med 2001; 7:37-42.

57. Bettan M, Emmanuel F, Darteil R, Caillaud JM, Soubrier F, Delaere P, Branelec D, Mahfoudi A, Duverger N, Scherman D. High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol Ther 2000; 2:204-210.

58. Abruzzese RV, Godin D, Mehta V, Perrard JL, French M, Nelson W, Howell G, Coleman M, O'Malley BW, Nordstrom JL. Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based autoinducible GeneSwitch system. Mol Ther 2000; 2: 276-287.

59. Rizzuto G, Cappelletti M, Maione D, Savino R, Lazzaro D, Costa P, Mathiesen I, Cortese R, Ciliberto G, Laufer R, La Monica N, Fattori E. Efficient and regulated erythropoietin production by naked DNA injection and muscle electropora-tion. Proc Natl Acad Sci USA 1999; 96:6417-6422.

60. Nathwani AC, Davidoff AM, Hanawa H, Hu Y, Hoffer FA, Nikanorov A, Slaughter C, Ng CY, Zhou J, Lozier JN, Man-drell TD, Vanin EF, Nienhuis AW. Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood 2002; 100:1662-1669.

61. Favre D, Provost N, Blouin V, Blancho G, Cherel Y, Salvetti A, Moullier P. Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle. Mol Ther 2001; 4:559-566.

62. Reynolds PN, Holmes MD, Adachi Y, Kaliberova L, Curiel DT. A novel system for mitigation of ectopic transgene expression induced by adenoviral vectors. Gene Ther 2001; 8: 1271-1275.

63. ThomaC, Wieland S, Moradpour D, von Weizsacker F, Offen-sperger S, Madon J, Blum HE, Offensperger WB. Ligand-mediated retargeting of recombinant adenovirus for gene transfer in vivo. Gene Ther 2000; 7:1039-1045.

Liu F, Huang L. Improving plasmid DNA-mediated liver gene transfer by prolonging its retention in the hepatic vasculature. J Gene Med 2001; 3:569-576.

Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999; 10:1735-1737. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999; 6:1258-1266.

Jaroszeski MJ, Coppola D, Pottinger C, Benson K, Gilbert RA, Heller R. Treatment of hepatocellular carcinoma in a rat model using electrochemotherapy. Eur J Cancer 2001; 37: 422-430.

Baba M, Iishi H, Tatsuta M. Transfer of bcl-xs plasmid is effective in preventing and inhibiting rat hepatocellular carcinoma induced by N-nitrosomorpholine. Gene Ther 2001; 8: 1149-1156.

Muramatsu T, Ito N, Tamaoki N, Oda H, Park HM. In vivo gene electroporation confers nutritionally-regulated foreign gene expression in the liver. Int J Mol Med 2001; 7:61-66. Dujardin N, Staes E, Kalia Y, Clarys P, Guy R, Preat V. In vivo assessment of skin electroporation using square wave pulses. J Control Release 2002; 79:219-227. Dujardin N, Van Der SP, Preat V. Topical gene transfer into rat skin using electroporation. Pharm Res 2001; 18:61-66. Drabick JJ, Glasspool-Malone J, King A, Malone RW. Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther 2001; 3:249-255. Glasspool-Malone J, Somiari S, Drabick JJ, Malone RW. Efficient nonviral cutaneous transfection. Mol Ther 2000; 2: 140-146.

Watkins C, Lau S, Thistlethwaite R, Hopkins J, Harkiss GD. Analysis of reporter gene expression in ovine dermis and afferent lymph dendritic cells in vitro and in vivo. Vet Immunol Immunopathol 1999; 72:125-133.

Rothermel BA, McKinsey TA, Vega RB, Nicol RL, Mammen P, Yang J, Antos CL, Shelton JM, Bassel-Duby R, Olson EN, Williams RS. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 2001; 98:3328-3333. Belehradek J, Orlowski S, Poddevin B, Paoletti C, Mir LM. Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer 1991; 27:73-76.

Mir LM, Orlowski S, Belehradek J, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 1991; 27:68-72. Rodriguez-Cuevas S, Barroso-Bravo S, Almanza-Estrada J, Cristobal-Martinez L, Gonzalez-Rodriguez E. Electrochemo-therapy in primary and metastatic skin tumors: Phase II trial using intralesional bleomycin. Arch Med Res 2001; 32: 273-276.

Mir LM, Devauchelle P, Quintin-Colonna F, Delisle F, Doliger S, Fradelizi D, Belehradek J, Orlowski S. First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br J Cancer 1997; 76:1617-1622.

Belehradek M, Domenge C, Luboinski B, Orlowski S, Beleh-radek J, Mir LM. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial Cancer 1993; 72: 3694-3700.

Heller L, Pottinger C, Jaroszeski MJ, Gilbert R, Heller R. In vivo electroporation of plasmids encoding GM-CSF or in-terleukin-2 into existing B16 melanomas combined with elec-trochemotherapy induces long-term antitumour immunity. Melanoma Res 2000; 10:577-583.

82. Lucas ML, Heller R. Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle. Mol Ther 2001; 3:47-53.

83. Wang F, Tian Y, Li L, Chen X, Hu H, Li C, Huang Q. Inhibita-tion of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2002; 34:165-170.

84. Cichon T, Jamrozy L, Glogowska J, Missol-Kolka E, Szala S. Electrotransfer of gene encoding endostatin into normal and neoplastic mouse tissues: Inhibition of primary tumor growth and metastatic spread. Cancer Gene Ther 2002; 9:771-777.

85. Shibata MA, Morimoto J, Otsuki Y. Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation. Cancer Gene Ther 2002; 9:16-27.

86. Heller LC, Coppola D. Electrically mediated delivery of vector plasmid DNA elicits an antitumor effect. Gene Ther 2002; 9: 1321-1325.

87. Lefesvre P, Attema J, Van Bekkum D. A comparison of efficacy and toxicity between electroporation and adenoviral gene transfer. BMC Mol Biol 2002; 3:12.

88. Mir LM. Therapeutic perspectives of in vivo cell electroper-meabilization. Bioelectrochemistry 2001; 53:1-10.

89. Greco O, Scott SD, Marples B, Dachs GU. Cancer gene therapy: Delivery, delivery, delivery. Front Biosci 2002; 7: d1516-24.:d1516-d1524.

90. Blair-Parks K, Weston BC, Dean DA. High-level gene transfer to the cornea using electroporation. J Gene Med 2002; 4: 92-100.

91. Dezawa M, Takano M, Negishi H, Mo X, Oshitari T, Sawada H. Gene transfer into retinal ganglion cells by in vivo electroporation: A new approach. Micron 2002; 33:1-6.

92. Mo X, Yokoyama A, Oshitari T, Negishi H, Dezawa M, Mi-zota A, Adachi-Usami E. Rescue of axotomized retinal ganglion cells by BDNF gene electroporation in adult rats. Invest Ophthalmol Vis Sci 2002; 43:2401-2405.

93. Harrison RL, Byrne BJ, Tung L. Electroporation-mediated gene transfer in cardiac tissue. FEBS Lett 1998; 435:1-5.

94. Nakamura H, Isaka Y, Tsujie M, Rupprecht HD, Akagi Y, Ueda N, Imai E, Hori M. Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial alpha-smooth muscle actin expression and fibrosis in unilateral urethral obstruction (UUO) rats. Gene Ther 2002; 9:495-502.

95. Sato M, Ishikawa A, Kimura M. Direct injection of foreign DNA into mouse testis as a possible in vivo gene transfer system via epididymal spermatozoa. Mol Reprod Dev 2002; 61:49-56.

96. Yamazaki Y, Yagi T, Ozaki T, Imoto K. In vivo gene transfer to mouse spermatogenic cells using green fluorescent protein as a marker. J Exp Zool 2000; 286:212-218.

97. Yomogida K, Yagura Y, Nishimune Y. Electroporated transgene-rescued spermatogenesis in infertile mutant mice with a sertoli cell defect. Biol Reprod 2002; 67:712-717.

98. Davalos RV, Rubinsky B, Otten DM. A feasibility study for electrical impedance tomography as a means to monitor tissue electroporation for molecular medicine. IEEE Trans Biomed Eng 2002; 49:400-403.

99. Martin GT, Pliquett UF, Weaver JC. Theoretical analysis of localized heating in human skin subjected to high voltage pulses. Bioelectrochemistry 2002; 57:55-64.

100. Pliquett UF, Martin GT, Weaver JC. Kinetics of the temperature rise within human stratum corneum during electroporation and pulsed high-voltage iontophoresis. Bioelectrochemistry 2002; 57:65-72.

101. Lee RC, Zhang D, Hannig J. Biophysical injury mechanisms in electrical shock trauma. Annu Rev Biomed Eng 2000; 2: 477-509.

102. Lucas ML, Heller R, Somiari S, Glasspool-Malone J, Drabick JJ, Gilbert RA, Heller R, Jaroszeski MJ, Malone RW. Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle. Mol Ther 2000; 2: 178-187.

103. Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM, Delaere P, Branellec D, Schwartz B, Scherman D. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 1999; 96:4262-4267.

104. Maruyama H, Ataka K, Gejyo F, Higuchi N, Ito Y, Hirahara H, Imazeki I, Hirata M, Ichikawa F, Neichi T, Kikuchi H, Sugawa M, Miyazaki J. Long-term production of erythropoie-tin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats. Gene Ther 2001; 8:461-468.

105. Yamashita YI, Shimada M, Hasegawa H, Minagawa R, Riki-maru T, Hamatsu T, Tanaka S, Shirabe K, Miyazaki JI, Sugi-machi K. Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. Cancer Res 2001; 61:1005-1012.

106. Bureau MF, Gehl J, Deleuze V, Mir LM, Scherman D. Importance of association between permeabilization and electropho-retic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta 2000; 1474:353-359.

107. Satkauskas S, Bureau MF, Puc M, Mahfoudi A, Scherman D, Miklavcic D, Mir LM. Mechanisms of in vivo DNA elec-trotransfer: Respective contributions of cell electropermeabili-zation and DNA electrophoresis. Mol Ther 2002; 5:133-140.

108. Tanaka M, Borgeld HJ, Zhang J, Muramatsu S, Gong JS, Yoneda M, Maruyama W, Naoi M, Ibi T, Sahashi K, Shamoto M, Fuku N, Kurata M, Yamada Y, Nishizawa K, Akao Y, Ohishi N, Miyabayashi S, Umemoto H, Muramatsu T, Furu-kawa K, Kikuchi A, Nakano I, Ozawa K, Yagi K. Gene therapy for mitochondrial disease by delivering restriction endonucle-ase smal into mitochondria. J Biomed Sci 2002; 9:534-541.

109. Kalat M, Kupcu Z, Schuller S, Zalusky D, Zehetner M, Paster W, Schweighoffer T. In vivo plasmid electroporation induces tumor antigen-specific CD8 + T-cell responses and delays tumor growth in a syngeneic mouse melanoma model. Cancer Res 2002; 62:5489-5494.

110. Peretz Y, Zhou Z, Halwani F, Prud'homme G. In vivo generation of dendritic cells by intramuscular codelivery of FLT3 ligand and GM-CSF plasmids. Mol Ther 2002; 6:407.

111. Pradat PF, Kennel P, Naimi-Sadaoui S, Finiels F, Scherman D, Orsini C, Delaere P, Mallet J, Revah F. Viral and non-viral gene therapy partially prevents experimental cisplatin-induced neuropathy. Gene Ther 2002; 9:1333-1337.

112. Babiuk S, Baca-Estrada M, Foldvaii M, Storms M, Rabussay D, Widera G, Babiuk L. Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 2002; 20:3399.

113. Kishimoto KN, Watanabe Y, Nakamura H, Kokubun S. Ec-topic bone formation by electroporatic transfer of bone mor-phogenetic protein-4 gene. Bone 2002; 31:340-347.

114. Adachi O, Nakano A, Sato O, Kawamoto S, Tahara H, Toyoda N, Yamato E, Matsumori A, Tabayashi K, Miyazaki J. Gene transfer of Fc-fusion cytokine by in vivo electroporation: Application to gene therapy for viral myocarditis. Gene Ther 2002; 9:577-583.

115. Xue F, Takahara T, Yata Y, Minemura M, Morioka CY, Taka-hara S, Yamato E, Dono K, Watanabe A. Attenuated acute liver injury in mice by naked hepatocyte growth factor gene transfer into skeletal muscle with electroporation. Gut 2002; 50:558-562.

116. Yamamoto M, Kobayashi Y, Li M, Niwa H, Mitsuma N, Ito Y, Muramatsu T, Sobue G. In vivo gene electroporation of glial cell line-derived neurotrophic factor (GDNF) into skeletal muscle of SOD1 mutant mice. Neurochem Res 2001; 26: 1201-1207.

117. Gehl J, Skovsgaard T, Mir LM. Vascular reactions to in vivo electroporation: Characterization and consequences for drug and gene delivery. Biochim Biophys Acta 2002; 1569:51-58.

118. Satkauskas S, Bureau MF, Mahfoudi A, Mir LM. Slow accumulation of plasmid in muscle cells: Supporting evidence for a mechanism of DNA uptake by receptor-mediated endocytosis. Mol Ther 2001;4:317-323.

119. Mallat Z, Corbaz A, Scoazec A, Graber P, Alouani S, Esposito B, Humbert Y, Chvatchko Y, Tedgui A. Interleukin-18/in-terleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 2001; 89: E41-E45.

120. Honigman A, Zeira E, Ohana P, Abramovitz R, Tavor E, Bar I, Zilberman Y, Rabinovsky R, Gazit D, Joseph A, Panet A, Shai E, Palmon A, Laster M, Galun E. Imaging transgene expression in live animals. Mol Ther 2001; 4:239-249.

121. Watanabe K, Nakazawa M, Fuse K, Hanawa H, Kodama M, Aizawa Y, Ohnuki T, Gejyo F, Maruyama H, Miyazaki J. Protection against autoimmune myocarditis by gene transfer of interleukin-10 by electroporation. Circulation 2001; 104: 1098-1100.

122. Kishida T, Asada H, Satoh E, Tanaka S, Shinya M, Hirai H, Iwai M, Tahara H, Imanishi J, Mazda O. In vivo electropora-tion-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice. Gene Ther 2001; 8:1234-1240.

123. Nakano A, Matsumori A, Kawamoto S, Tahara H, Yamato E, Sasayama S, Miyazaki JI. Cytokine gene therapy for myocarditis by in vivo electroporation. Hum Gene Ther 2001; 12: 1289-1297.

124. Yin D, Tang JG. Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo. FEBS Lett 2001; 495:16-20.

125. Li S, MacLaughlin FC, Fewell JG, Gondo M, Wang J, Nicol F, Dean DA, Smith LC. Muscle-specific enhancement of gene expression by incorporation of SV40 enhancer in the expression plasmid. Gene Ther 2001; 8:494-497.

126. Jiang Y, Wang M, Celiker MY, Liu YE, Sang QX, Goldberg ID, Shi YE. Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery. Cancer Res 2001; 61:2365-2370.

127. Pradat PF, Finiels F, Kennel P, Naimi S, Orsini C, Delaere P, Revah F, Mallet J. Partial prevention of cisplatin-induced neuropathy by electroporation-mediated nonviral gene transfer. Hum Gene Ther 2001; 12:367-375.

128. Uno-Furuta S, Tamaki S, Takebe Y, Takamura S, Kamei A, Kim G, Kuromatsu I, Kaito M, Adachi Y, Yasutomi Y. Induction of virus-specific cytotoxic T lymphocytes by in vivo electric administration of peptides. Vaccine 2001; 19:2190-2196.

129. Zucchelli S, Capone S, Fattori E, Folgori A, Di Marco A, Casimiro D, Simon AJ, Laufer R, La Monica N, Cortese R, Nicosia A. Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol 2000; 74:11598-11607.

130. Chapdelaine P, Moisset PA, Campeau P, Asselin I, Vilquin JT, Tremblay JP. Functional EGFP-dystrophin fusion proteins for gene therapy vector development. Protein Eng 2000; 13: 611-615.

131. Selby M, Goldbeck C, Pertile T, Walsh R, Ulmer J. Enhancement of DNA vaccine potency by electroporation in vivo. J Biotechnol 2000; 83:147-152.

Hoover F, Magne KJ. A double-injection DNA electroporation protocol to enhance in vivo gene delivery in skeletal muscle. Anal Biochem 2000; 285:175-178. Dupuis M, Denis-Mize K, Woo C, Goldbeck C, Selby MJ, Chen M, Otten GR, Ulmer JB, Donnelly JJ, Ott G, McDonald DM. Distribution of DNA vaccines determines their immuno-genicity after intramuscular injection in mice. J Immunol 2000; 165:2850-2858.

Widera G, Austin M, Rabussay D, Goldbeck C, Barnett SW, Chen M, Leung L, Otten GR, Thudium K, Selby MJ, Ulmer JB. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 2000; 164:4635-4640. Maruyama H, Sugawa M, Moriguchi Y, Imazeki I, Ishikawa Y, Ataka K, Hasegawa S, Ito Y, Higuchi N, Kazama JJ, Gejyo F, Miyazaki JI. Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation. Hum Gene Ther 2000; 11:429-437.

Celiker MY, Wang M, Atsidaftos E, Liu X, Liu YE, Jiang Y, Valderrama E, Goldberg ID, Shi YE. Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA. Oncogene 2001; 20: 4337-4343.

Hanna E, Zhang X, Woodlis J, Breau R, Suen J, Li S. Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site. Cancer Gene Ther 2001; 8:151-157.

Chen Z, Kadowaki S, Hagiwara Y, Yoshikawa T, Sata T, Kur-ata T, Tamura S. Protection against influenza B virus infection by immunization with DNA vaccines. Vaccine 2001; 19: 1446-1455.

Konig S, Burkman J, Fitzgerald J, Mitchell M, Su L, Stedman H. Modular organization of phylogenetically conserved domains controlling developmental regulation of the human skeletal myosin heavy chain gene family. J Biol Chem 2002; 277: 27593-27605.

Kreiss P, Bettan M, Crouzet J, Scherman D. Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer. J Gene Med 1999; 1:245-250. Li S, Zhang X, Xia X, Zhou L, Breau R, Suen J, Hanna E. Intramuscular electroporation delivery of IFN-alpha gene therapy for inhibition of tumor growth located at a distant site. Gene Ther 2001; 8:400-407.

Lawson BR, Prud'homme GJ, Chang Y, Gardner HA, Kuan J, Kono DH, Theofilopoulos AN. Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc. J Clin Invest 2000; 106:207-215.

Liu F, Huang L. A syringe electrode device for simultaneous injection of DNA and electrotransfer. Mol Ther 2002; 5: 323-328.

Rizzuto G, Cappelletti M, Mennuni C, Wiznerowicz M, De-Martis A, Maione D, Ciliberto G, Monica N, Fattori E. Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. Hum Gene Ther 2000; 11:1891-1900.

Mendiratta SK, Thai G, Eslahi NK, Thull NM, Matar M, Bronte V, Pericle F. Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2. Cancer Res 2001; 61:859-863.

Samakoglu S, Fattori E, Lamartina S, Toniatti C, Stockholm D, Heard JM, Bohl D. betaMinor-globin messenger RNA accumulation in reticulocytes governs improved erythropoiesis in beta thalassemic mice after erythropoietin complementary DNA electrotransfer in muscles. Blood 2001; 97:2213-2220. Tanaka T, Ichimaru N, Takahara S, Yazawa K, Hatori M, Suzuki K, Isaka Y, Moriyama T, Imai E, Azuma H, Nakamura T, Okuyama A, Yamanaka H. In vivo gene transfer of hepato-

cyte growth factor to skeletal muscle prevents changes in rat kidneys after 5/6 nephrectomy. Am J Transplant 2002; 2: 828-836.

148. Tollefsen S, TjelleT, Schneider J, HarboeM, Wiker H, Hewin-son G, Huygen K, Mathiesen I. Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation. Vaccine 2002; 20:3370-3378.

149. Vicat JM, Boisseau S, Jourdes P, Laine M, Wion D, Bouali-Benazzouz R, Benabid AL, Berger F. Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression. Hum Gene Ther 2000; 11:909-916.

150. Cemazar M, Sersa G, Wilson J, Tozer GM, Hart SL, Grosel A, Dachs GU. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: Electroporation, liposomes, and integrin-targeted vector. Cancer Gene Ther 2002; 9:399-406.

151. Tanaka S, Sugimachi K, Yamashita YY, Ohga T, Shirabe K, Shimada M, Wands JR, Sugimachi K. Tie2 vascular endothe-lial receptor expression and function in hepatocellular carcinoma. Hepatology 2002; 35:861-867.

152. Yamashita Y, Shimada M, Tanaka S, Okamamoto M, Miyazaki J, Sugimachi K. Electroporation-mediated tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L gene therapy for hepatocellular carcinoma. Hum Gene Ther 2002; 13:275-286.

153. Tomizawa M, Ebara M, Saisho H, Sakiyama S, Tagawa M. Irradiation with ultrasound of low output intensity increased chemosensitivity of subcutaneous solid tumors to an anti-cancer agent. Cancer Lett 2001; 173:31-35.

154. Tamura T, Nishi T, Goto T, Takeshima H, Dev SB, Ushio Y, Sakata T. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer. Hum Gene Ther 2001; 12:1265-1276.

155. Lohr F, Lo DY, Zaharoff DA, Hu K, Zhang X, Li Y, Zhao Y, Dewhirst MW, Yuan F, Li CY. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo elec-troporation. Cancer Res 2001; 61:3281-3284.

156. Heller L, Jaroszeski MJ, Coppola D, Pottinger C, Gilbert R, Heller R. Electrically mediated plasmid DNA delivery to hepa-tocellular carcinomas in vivo. Gene Ther 2000; 7:826-829.

157. Wells JM, Li LH, Sen A, Jahreis GP, Hui SW. Electroporation-enhanced gene delivery in mammary tumors. Gene Ther 2000; 7:541-547.

158. Yoshizato K, Nishi T, Goto T, Dev SB, Takeshima H, Kino T, Tada K, Kimura T, Shiraishi S, Kochi M, Kuratsu JI, Hofmann GA, Ushio Y. Gene delivery with optimized electropora-tion parameters shows potential for treatment of gliomas. Int J Oncol 2000; 16:899-905.

159. Goto T, Nishi T, Tamura T, Dev SB, Takeshima H, Kochi M, Yoshizato K, Kuratsu J, Sakata T, Hofmann GA, Ushio Y. Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci USA 2000; 97:354-359.

160. Niu G, Shain KH, Huang M, Ravi R, Bedi A, Dalton WS, Jove R, Yu H. Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest. Cancer Res 2001; 61: 3276-3280.

161. Rols MP, Delteil C, Golzio M, Dumond P, Cros S, Teissie J. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 1998; 16:168-171.

162. Heller R, Schultz J, Lucas ML, Jaroszeski MJ, Heller LC, Gilbert RA, Moelling K, Nicolau C. Intradermal delivery of interleukin-12 plasmid DNA by in vivo electroporation. DNA Cell Biol 2001; 20:21-26.

163. Chesnoy S, Huang L. Enhanced cutaneous gene delivery following intradermal injection of naked DNA in a high ionic strength solution. Mol Ther 2002; 5:57-62.

164. Lin CR, Yang LC, Lee TH, Lee CT, Huang HT, Sun WZ, Cheng JT. Electroporation-mediated pain-killer gene therapy for mononeuropathic rats. Gene Ther 2002; 9:1247-1253.

165. Lin CR, Tai MH, Cheng JT, Chou AK, Wang JJ, Tan PH, Marsala M, Yang LC. Electroporation for direct spinal gene transfer in rats. Neurosci Lett 2002; 317:1-4.

166. Haas K, Sin WC, Javaherian A, Li Z, Cline HT. Single-cell electroporation for gene transfer in vivo. Neuron 2001; 29: 583-591.

167. Tanaka S, Uehara T, Nomura Y. Up-regulation of proteindisulfide isomerase in response to hypoxia/brain ischemia and its protective effect against apoptotic cell death. J Biol Chem 2000; 275:10388-10393.

168. Araki I, Nakamura H. Engrailed defines the position of dorsal dimesencephalic boundary by repressing diencephalic fate. Development 1999; 126:5127-5135.

169. Akamatsu W, Okano HJ, Osumi N, Inoue T, Nakamura S, Sakakibara S, Miura M, Matsuo N, Darnell RB, Okano H. Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems. Proc Natl Acad Sci USA 1999; 96:9885-9890.

170. Saito T, Nakatsuji N. Efficient gene transfer into the embryonic mouse brain using in vivo electroporation. Dev Biol 2001; 240:237-246.

171. Treubert-Zimmermann U, Heyers D, Redies C. Targeting axons to specific fiber tracts in vivo by altering cadherin expression. J Neurosci 2002; 22:7617-7626.

172. Kadowaki S, Chen Z, Asanuma H, Aizawa C, Kurata T, Ta-mura S. Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation. Vaccine 2000; 18:2779-2788.

173. Oshima Y, Sakamoto T, Hisatomi T, Tsutsumi C, Sassa Y, Ishibashi T, Inomata H. Targeted gene transfer to corneal stroma in vivo by electric pulses. Exp Eye Res 2002; 74: 191-198.

174. Ohashi S, Kubo T, Kishida T, Ikeda T, Takahashi K, Arai Y, Terauchi R, Asada H, Imanishi J, Mazda O. Successful genetic transduction in vivo into synovium by means of electropora-tion. Biochem Biophys Res Commun 2002; 293:1530-1535.

175. Koshiba-Takeuchi K, Takeuchi JK, Matsumoto K, Momose T, Uno K, Hoepker V, Ogura K, Takahashi N, Nakamura H, Yasuda K, Ogura T. Tbx5 and the retinotectum projection. Science 2000; 287:134-137.

176. Oshima Y, Sakamoto T, Yamanaka I, Nishi T, Ishibashi T, Inomata H. Targeted gene transfer to corneal endothelium in vivo by electric pulse. Gene Ther 1998; 5:1347-1354.

177. Sugihara K, Park HM, Muramatsu T. Foreign gene expression by in vivo gene electroporation in the quail testis. Comp Biochem Physiol B Biochem Mol Biol 2000; 125:47-52.

178. Yoo JJ, Soker S, Lin LF, Mehegan K, Guthrie PD, Atala A. Direct in vivo gene transfer to urological organs. J Urol 1999; 162:1115-1118.

179. Harimoto K, Sugimura K, Lee CR, Kuratsukuri K, Kishimoto T. In vivo gene transfer methods in the bladder without viral vectors. Br J Urol 1998; 81:870-874.

180. Magee TR, Ferrini M, Garban HJ, Vernet D, Mitani K, Rajfer J-, Cadavid NF. Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase. Biol Reprod 2002; 67:20-28.

181. Takami H, Watanabe H, Ohmori Y, Park HM, Muramatsu T. Human alkaline phosphatase expression and secretion into chicken eggs after in vivo gene electroporation in the oviduct of laying hens. Biochem Biophys Res Commun 2002; 292: 88-93.

182. Park HM, Muramatsu T. In vivo manipulation of foreign gene expression by steroid administration in the oviduct of laying hens. J Endocrinol 1999; 163:173-179.

183. Suzuki T, Shin BC, Fujikura K, Matsuzaki T, Takata K. Direct gene transfer into rat liver cells by in vivo electroporation. FEBS Lett 1998; 425:436-440.

184. Duchler M, Pengg M, Schuller S, Pfneisl F, Bugingo C, Brem

G, Wagner E, Schellander K, Muller M. Somatic gene transfer into the lactating ovine mammary gland. J Gene Med 2002; 4:282-291.

185. Martin JB, Young JL, Benoit JN, Dean DA. Gene transfer to intact mesenteric arteries by electroporation. J Vasc Res 2000; 37:372-380.

186. Takahashi N, Enosawa S, Mitani T, Lu H, Suzuki S, Amemiya

H, Amano T, Sakuragawa N. Transplantation of amniotic epithelial cells into fetal rat liver by in utero manipulation. Cell Transplant 2002; 11:443-449.

187. Kos R, Reedy MV, Johnson RL, Erickson CA. The winged-helix transcription factor FoxD3 is important for establishing the neural crest lineage and repressing melanogenesis in avian embryos. Development 2001; 128:1467-1479.

188. Agarwala S, Sanders TA, Ragsdale CW. Sonic hedgehog control of size and shape in midbrain pattern formation. Science 2001; 291:2147-2150.

189. Atkins RL, Wang D, Burke RD. Localized electroporation: A method for targeting expression of genes in avian embryos. Biotechniques 2000; 28:94-6, 98, 100.

190. Calegari F, Haubensak W, Yang D, Huttner WB, Buchholz F. Tissue-specific RNA interference in postimplantation mouse embryos with endoribonuclease-prepared short interfering RNA. Proc Natl Acad Sci USA 2002; 99:14236-14240.

191. del Barrio MG, Nieto MA. Overexpression of snail family members highlights their ability to promote chick neural crest formation. Development 2002; 129:1583-1593.

192. Dickinson ME, Waters CW, Murray BA, Haynes SM, Long-muir KJ. Using electroporation and lipid-mediated transfection of GFP-expressing plasmids to label embryonic avian cells for vital confocal and two-photon microscopy. Differentiation 2002; 70:172-180.

193. Funahashi J, Okafuji T, Ohuchi H, Noji S, Tanaka H, Naka-mura H. Role of Pax-5 in the regulation of a mid-hindbrain organizer's activity. Dev Growth Differ 1999; 41:59-72.

194. Grapin-Botton A, Majithia AR, Melton DA. Key events of pancreas formation are triggered in gut endoderm by ectopic expression of pancreatic regulatory genes. Genes Dev 2001; 15:444-454.

195. Giudicelli F, Taillebourg E, Charnay P, Gilardi-Hebenstreit P. Krox-20 patterns the hindbrain through both cell-autonomous and non cell-autonomous mechanisms. Genes Dev 2001; 15: 567-580.

196. Hong YM, Kannen S, Thanos S. Asymmetric mRNA expression in the retinal neuroepithelium of the chick embryo assessed by differential display polymerase chain reaction. Neuroreport 1998; 9:2405-2408.

197. Mellitzer G, Hallonet M, Chen L, Ang S. Spatial and temporal 'knock down' of gene expression by electroporation of double-stranded RNA and morpholinos into early postimplantation mouse embryos. Mech Dev 2002; 118:57.

198. Inoue T, Tanaka T, Takeichi M, Chisaka O, Nakamura S, Osumi N. Role of cadherins in maintaining the compartment boundary between the cortex and striatum during development. Development 2001; 128:561-569.

199. Nakamura H, Funahashi J. Introduction of DNA into chick embryos by in ovo electroporation. Methods 2001; 24:43-48.

200. Swartz ME, Eberhart J, Pasquale EB, Krull CE. EphA4/ephrin-A5 interactions in muscle precursor cell migration in the avian forelimb. Development 2001; 128:4669-4680.

201. Tabata H, Nakajima K. Efficient in utero gene transfer system to the developing mouse brain using electroporation: Visualization of neuronal migration in the developing cortex. Neuroscience 2001; 103:865-872.

202. Takahashi M, Osumi N. Pax6 regulates specification of ventral neurone subtypes in the hindbrain by establishing progenitor domains. Development 2002; 129:1327-1338.

203. Yu RT, Chiang MY, Tanabe T, Kobayashi M, Yasuda K, Evans RM, Umesono K. The orphan nuclear receptor Tlx regulates Pax2 and is essential for vision. Proc Natl Acad Sci USA 2000; 97:2621-2625.

204. Zhu CC, Dyer MA, Uchikawa M, Kondoh H, Lagutin OV, Oliver G. Six3-mediated auto repression and eye development requires its interaction with members of the Groucho-related family of co-repressors. Development 2002; 129:2835-2849.

How To Bolster Your Immune System

How To Bolster Your Immune System

All Natural Immune Boosters Proven To Fight Infection, Disease And More. Discover A Natural, Safe Effective Way To Boost Your Immune System Using Ingredients From Your Kitchen Cupboard. The only common sense, no holds barred guide to hit the market today no gimmicks, no pills, just old fashioned common sense remedies to cure colds, influenza, viral infections and more.

Get My Free Audio Book


Post a comment